U.S. flag

An official website of the United States government, Department of Justice.

Briefing on PMP Effectiveness -- Prescription Monitoring Programs: An Effective Tool in Curbing the Prescription Drug Abuse Epidemic

NCJ Number
241874
Date Published
Agencies
BJA-Sponsored
Publication Type
Report (Grant Sponsored), Program/Project Evaluation, Program/Project Description
Grant Number(s)
2009-PM-BX-K044
Annotation
This report concludes that there is growing evidence that prescription monitoring programs (PMPs) are effective in reducing diversion of controlled substances, improving clinical decisionmaking, and assisting in other efforts to curb the prescription drug abuse epidemic.
Abstract
The importance of PMPs is clear from evidence that addiction, overdoses, and deaths that involve non-medical prescription drug use have increased significantly over the last decade, surpassing those due to illicit drugs such as heroin and cocaine. Narcotic pain relievers are the most abused of the non-medical prescription drugs. PMPs collect data from pharmacies on dispensed controlled substance prescriptions. PMPs are important tools in curbing major sources of prescription drug diversion, which include prescription fraud, forgeries, doctor shopping, and medically unwarranted prescribing by some practitioners and pharmacists. Currently, 48 States and 1 U.S. Territory have enacted legislation that establishes a PMP; 38 States have operational PMPs. This report presents a sampling of studies that show PMPs can help in improving prescribing procedures and reducing the diversion of controlled substances. The studies indicate that States with PMPs and States with pro-active PMPs have lower rates of treatment admissions for the abuse of prescription drugs, reduced doctor shopping, and less diversion of non-medical prescription drugs. Also, States with PMPs have smaller increases in opiate exposures related to abuse and misuse, as well as lower outpatient drug claims. In addition, States without PMPs are more likely to experience higher rates of controlled substance distribution. Studies also indicate that PMP data have assisted in the investigation of drug diversion and reduced the number of investigations needed. Other benefits of PMPs include assisting in drug abuse prevention and surveillance, as well as the validation of patient self-reports on the use of medications. 35 notes
Date Created: December 26, 2019